XML 37 R28.htm IDEA: XBRL DOCUMENT v3.25.0.1
Organization and Summary of Significant Accounting Policies - Additional Information (Detail)
 12 Months Ended
Dec. 31, 2024
USD ($)
Reporting_unit
Segment
shares
Dec. 31, 2023
USD ($)
shares
Basis Of Presentation And Summary Of Significant Accounting Policies [Line Items]    
Investments $ 0 $ 0
Number of operating segment | Segment 1  
Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration] srt:ChiefExecutiveOfficerMember, srt:ChiefFinancialOfficerMember, Chief Medical Officer [Member]  
Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description The CODM assesses performance for the segment and decides how to allocate resources based on consolidated net loss as reported on the statement of operations, after taking into account the Company's strategic priorities, its cash balance, and its expected use of cash. Further, the CODM reviews and utilizes functional expenses (i.e., research, development, and patent expense, and general and administrative) at the consolidated level to manage the Company's operations.  
Segment Reporting, Other Segment Item, Composition, Description Other segment items included in consolidated net loss are revenues, stock-based compensation, depreciation and amortization, interest income, other expense, net, and income tax expense, which are reflected in the consolidated statements of operations and comprehensive loss.  
Cash insured amount $ 250,000  
Number of reportable unit | Reporting_unit 1  
Research and development costs $ 6,800,000 5,300,000
Patent-related expenses 400,000 400,000
Clinical trial accruals 700,000 1,000,000.0
Prepaid expenses $ 500,000 $ 0.0
Potentially dilutive outstanding securities stock option excluded from diluted net loss per common share | shares 7,040,894 7,781,749
Partially reimburse the costs of the studies $ 700,000  
Research and development costs $ 700,000  
Minimum    
Basis Of Presentation And Summary Of Significant Accounting Policies [Line Items]    
Stock option, vesting period 3 years  
Maximum    
Basis Of Presentation And Summary Of Significant Accounting Policies [Line Items]    
Stock option, vesting period 4 years